Nicotine pouches are selling themselves as wellness, sitting on shelves next to vitamin supplements and adaptogens, unmarked by tobacco warnings or age restrictions, positioned as aids for focus or stress relief rather than delivery devices for an addictive stimulant.
We have seen this exact architecture before. In 1970, the Federal Trade Commission allowed cigarette companies to market "light" and "low-tar" brands with minimal restrictions — Philip Morris and others flooded markets with filtered alternatives, each positioned as medically safer despite zero clinical evidence.
The regulatory structure that governed tobacco remained in place, but the marketing message simply reframed the product. Smokers believed they were reducing harm. They were not.
The FTC eventually cracked down in 2000, ordering these companies to stop making unsubstantiated harm-reduction claims. The settlement cost billions, and the lesson seemed clear. Regulatory frameworks work only when they apply uniformly to the product category. Nicotine pouches have solved this problem. They exist in the gaps between cigarettes and pharmaceutical drugs. They are not tobacco, so they escape tobacco marketing restrictions. They are not medicines, so they avoid FDA pre-approval scrutiny. The companies selling them have learned what their predecessors did not. They should not argue the science within the existing framework but instead change the framework and position the product outside it entirely.
Do not argue the science within the existing framework. Change the framework.
”Consumers looking at nicotine pouches are carrying a map that assumes transparency, regulation, and honesty in product positioning. They assume that if something is sold as wellness, it has been evaluated as wellness. That displacement from tobacco equals displacement from risk. They are reading the new delivery method as a changed product, when what has actually changed is the regulatory home it shelters in. The next person you see making a large decision based on how a product repositioned itself — at work, in health, in how they spend. Is worth watching for this same invisible substitution of category for change.
Next time you see a product marketed as wellness or positioned differently from competitors, ask: did the thing actually change, or just which regulatory category it lives in?